Clinical Trial Update: NOVOCART®3D for Treatment of Articular Cartilage of the Knee [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for NOVOCART 3D to treat articular cartilage defects of the knee (femoral condyle, 2–6 cm2), sponsored by Aesculap Biologics; the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Articular Cartilage Defect of the Knee

Drugs mentioned

• NOVOCART 3D

Snippet

Sponsor: Aesculap Biologics, LLC | Conditions: Articular Cartilage of the Femoral Condyle Between 2-6cm2 | Phase 3 | Status: ACTIVE_NOT_RECRUITING